Cedarwood Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
874
+62
+8% +$63.3K 0.79% 29
2026
Q1
$747K Buy
812
+49
+6% +$49.7K 0.75% 29
2025
Q4
$811K Buy
+763
New +$730K 0.9% 26

Other funds holding LLY

Cedarwood Wealth's LLY Position: Q2 2026 in Review

Cedarwood Wealth increased its Eli Lilly (LLY) stake by 7.6% in Q2 2026, buying an estimated $63.3K and bringing the position to 874 shares worth $1.05M. The position accounts for 0.79% of the portfolio, ranked #29.

Cedarwood Wealth first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cedarwood Wealth held 874 shares of Eli Lilly worth $1.05M as of Q2 2026.
  • Cedarwood Wealth bought 62 Eli Lilly shares in Q2 2026, an estimated $63.3K.
  • Eli Lilly made up 0.79% of Cedarwood Wealth's portfolio in Q2 2026, its #29 holding.
  • Cedarwood Wealth first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cedarwood Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.